Chemistry Reference
In-Depth Information
[52] Dubinina, G. G., Chupryna, O. O., Platonov, M. O., Borisko, P. O., Ostrovska, G. V., Tolmachov,
A. O. and Shtil, A. A. (2007).
In silico
design of protein kinase inhibitors: successes and failures.
Anti-Cancer Agents Med. Chem.
7
, 171-188.
[53] Gronwald, W. and Kalbitzer, H. R. (2004). Automated structure determination of proteins by
NMR spectroscopy.
Prog. Nucl. Magn. Reson. Spectrosc
.
44
, 33-96.
[54] Grishaev,A. and Llinas, M. (2002). CLOUDS, a protocol for deriving amolecular proton density
via NMR.
Proc. Natl. Acad. Sci. USA
99
, 10941.
[55] Grishaev, A. and Llinas, M. (2002). Protein structure elucidation from NMR proton densities.
Proc. Natl. Acad. Sci. USA
99
, 6713-6718.
[56] Grishaev, A. and Llinas, M. (2005). Protein structure elucidation from minimal NMR data: The
CLOUDS approach.
Methods Enzymol
.
394
, 261-295.
[57] Ikeya, T., Terauchi, T., Guntert, P. and Kainosho, M. (2006). Evaluation of stereo-array isotope
labeling (SAIL) patterns for automated structural analysis of proteins with CYANA.
Magn.
Reson. Chem
.
44
, S152-S157.
[58] Kainosho, M., Torizawa, T., Iwashita, Y., Terauchi, T., Mei Ono, A. and Guentert, P. (2006).
Optimal isotope labelling for NMR protein structure determinations.
Nature
440
, 52-57.
[59] Lyne, P. D., Lamb, M. L. and Saeh, J. C. (2006). Accurate prediction of the relative potencies
of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring.
J. Med. Chem.
49
, 4805-4808.
[60] Kuhn, B., Gerber, P., Schulz-Gasch, T. and Stahl,M. (2005). Validation and use of theMM-PBSA
approach for drug discovery.
J. Med. Chem.
48
, 4040-4048.
[61] Teramoto, R. and Fukunishi, H. (2007). Supervised consensus scoring for docking and virtual
screening.
J. Chem. Inf. Model
.
47
, 526-534.
[62] Marin, A., Malliavin, T. E., Nicolas, P. and Delsuc, M.-A. (2004). From NMR chemical shifts
to amino acid types: investigation of the predictive power carried by nuclei.
J. Biomol. NMR
30
, 47-60.
